JP7579581B2 - 無煙たばこ製品におけるイソチオシアネートの使用 - Google Patents

無煙たばこ製品におけるイソチオシアネートの使用 Download PDF

Info

Publication number
JP7579581B2
JP7579581B2 JP2021566938A JP2021566938A JP7579581B2 JP 7579581 B2 JP7579581 B2 JP 7579581B2 JP 2021566938 A JP2021566938 A JP 2021566938A JP 2021566938 A JP2021566938 A JP 2021566938A JP 7579581 B2 JP7579581 B2 JP 7579581B2
Authority
JP
Japan
Prior art keywords
tobacco
isothiocyanate
ingestible product
nicotine
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021566938A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022539648A5 (fr
JP2022539648A (ja
Inventor
セス、アビナッシュ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gamot Global PteLtd
Original Assignee
Gamot Global PteLtd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gamot Global PteLtd filed Critical Gamot Global PteLtd
Publication of JP2022539648A publication Critical patent/JP2022539648A/ja
Publication of JP2022539648A5 publication Critical patent/JP2022539648A5/ja
Application granted granted Critical
Publication of JP7579581B2 publication Critical patent/JP7579581B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/281—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
    • A24B15/283—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed by encapsulation of the chemical substances
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/301—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by aromatic compounds
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
    • A24B15/303—Plant extracts other than tobacco
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/40—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms
    • A24B15/403—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms
    • A24B15/406—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms in a five-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2021566938A 2019-05-08 2020-05-07 無煙たばこ製品におけるイソチオシアネートの使用 Active JP7579581B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962844846P 2019-05-08 2019-05-08
US62/844,846 2019-05-08
PCT/US2020/031849 WO2020227512A1 (fr) 2019-05-08 2020-05-07 Utilisation d'isothiocyanate dans des produits de tabac sans fumée

Publications (3)

Publication Number Publication Date
JP2022539648A JP2022539648A (ja) 2022-09-13
JP2022539648A5 JP2022539648A5 (fr) 2023-04-04
JP7579581B2 true JP7579581B2 (ja) 2024-11-08

Family

ID=73046179

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021566938A Active JP7579581B2 (ja) 2019-05-08 2020-05-07 無煙たばこ製品におけるイソチオシアネートの使用

Country Status (6)

Country Link
US (2) US11730187B2 (fr)
EP (1) EP3955754B1 (fr)
JP (1) JP7579581B2 (fr)
CN (1) CN114340410A (fr)
SG (1) SG11202112374YA (fr)
WO (1) WO2020227512A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202112374YA (en) 2019-05-08 2021-12-30 Avinash Seth Use of isothiocyanate in smokeless tobacco products

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003081939A (ja) 2001-09-10 2003-03-19 New Food Creation Gijutsu Kenkyu Kumiai アブラナ科植物からイソチオシアネート類の製造方法
WO2004089126A1 (fr) 2003-04-01 2004-10-21 Shusei Takano Tuyau d'aspiration de nicotine et support de nicotine
JP2009126826A (ja) 2007-11-22 2009-06-11 Atsuo Sekiyama 抗ストレス剤
JP2012111948A (ja) 2010-11-24 2012-06-14 Symrise Ag メントール含有混合物
JP2018533916A (ja) 2015-09-16 2018-11-22 アレクサンドラ ディルマン 電子タバコによって供給される気化した液体の流れを処理するための方法および放出装置、および添加組成物を含有する気化した液体の経口摂取のための電子タバコ

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4810560B1 (fr) * 1969-02-13 1973-04-04
US6348220B1 (en) 1999-04-09 2002-02-19 Rutgers, The State University Of New Jersey Phenethylisothiocyanate nutraceutical compositions and methods
ATE276676T1 (de) * 2001-10-22 2004-10-15 Ivo Pera Zusammensetzung zur reduzierung oder entwöhnung von nikotinabhängigkeit
US6824796B2 (en) * 2002-06-21 2004-11-30 Access Business Group International Llc Extraction of non-polar isothiocyanates from plants
EP1841320A2 (fr) 2005-01-12 2007-10-10 S.U.L.V.E. Ltd. Procedes et compositions pharmaceutiques utilisees pour le traitement du psoriasis
US20080017207A1 (en) 2006-07-18 2008-01-24 Savipu Pharmaceuticals Reduction of the Deleterious Effects of Tobacco Smoking by the Induction of Phase 2 Enzymes by Nerf2
CN101120948A (zh) 2006-08-08 2008-02-13 普文英 一种具有化学保护、癌症预防和治疗用途的化合物组合物
JP5119546B2 (ja) 2007-07-05 2013-01-16 独立行政法人国立がん研究センター 胃を原発巣とする消化管間質腫瘍の悪性化の診断法
EP2173200B1 (fr) 2007-07-23 2017-11-15 R.J.Reynolds Tobacco Company Composition de tabac sans fumée, et procédés pour traiter le tabac destiné à y être utilisé
US20100178286A1 (en) * 2007-07-27 2010-07-15 Smith Walter P Methods and compositions for reducing facial lines and wrinkles
DE102008015101A1 (de) 2008-03-19 2009-09-24 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Kauzusammensetzung und deren Verwendung
US7715144B2 (en) 2008-03-31 2010-05-11 Kabushiki Kaisha Toshiba Track error measurement and recovery
CN101406319A (zh) 2008-11-06 2009-04-15 广东神农烟科技术有限公司 白藜芦醇低害香烟
EP2544699A4 (fr) 2010-03-11 2013-08-21 Health Research Inc Nouvelle méthode d'administration et d'utilisation d'isothiocyanates pour la prophylaxie et/ou le traitement du cancer de la vessie
US8222197B2 (en) 2010-03-12 2012-07-17 The Procter & Gamble Company Liquid detergent compositions comprising pH tuneable amido-gellants, and processes for making
US20120027693A1 (en) * 2010-07-27 2012-02-02 Bean Bruce P Methods and compositions for preventing and relieving muscle cramps and for recovery from neuromuscular irritability and fatigue following exercise
CN102008123B (zh) 2010-12-27 2013-04-10 邓卫永 一种制备孜然香烟的方法
WO2012142511A2 (fr) * 2011-04-15 2012-10-18 Md Matrix Health Llc Dba Md Matrix Health Inc Compositions orthomoléculaires et leur utilisation dans la stabilisation de la matrice extracellulaire
US8646461B2 (en) 2011-12-14 2014-02-11 Sentiens, Llc Device and method for simulating chemosensation of smoking
US20150068544A1 (en) * 2013-09-09 2015-03-12 R.J. Reynolds Tobacco Company Smokeless tobacco composition incorporating a botanical material
AU2014348212C1 (en) 2013-11-18 2018-11-29 Arcturus Therapeutics, Inc. Ionizable cationic lipid for RNA delivery
US9730916B2 (en) 2014-02-27 2017-08-15 Chang Gung Memorial Hospital, Keelung Nutritional composition and method for improving heart failure
US20160157515A1 (en) 2014-12-05 2016-06-09 R.J. Reynolds Tobacco Company Smokeless tobacco pouch
WO2016100430A1 (fr) 2014-12-18 2016-06-23 Csp Technologies, Inc. Agent microbicide pour améliorer la stabilité en conservation
US9867779B2 (en) * 2015-03-26 2018-01-16 Patheon Softgels Inc. Liquisoft capsules
CN106690232B (zh) * 2016-11-21 2021-03-30 青岛农业大学 一种富含异硫氰酸酯的蔬菜调味粉及其生产方法
CN106900962A (zh) 2017-01-19 2017-06-30 上海王室环保科技有限公司 一种戒烟糖及其制备方法
CN109381499B (zh) * 2017-08-07 2021-08-31 深圳福山生物科技有限公司 一种辣根组合物及其用途
SG11202112374YA (en) 2019-05-08 2021-12-30 Avinash Seth Use of isothiocyanate in smokeless tobacco products

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003081939A (ja) 2001-09-10 2003-03-19 New Food Creation Gijutsu Kenkyu Kumiai アブラナ科植物からイソチオシアネート類の製造方法
WO2004089126A1 (fr) 2003-04-01 2004-10-21 Shusei Takano Tuyau d'aspiration de nicotine et support de nicotine
JP2009126826A (ja) 2007-11-22 2009-06-11 Atsuo Sekiyama 抗ストレス剤
JP2012111948A (ja) 2010-11-24 2012-06-14 Symrise Ag メントール含有混合物
JP2018533916A (ja) 2015-09-16 2018-11-22 アレクサンドラ ディルマン 電子タバコによって供給される気化した液体の流れを処理するための方法および放出装置、および添加組成物を含有する気化した液体の経口摂取のための電子タバコ

Also Published As

Publication number Publication date
US12471620B2 (en) 2025-11-18
EP3955754A4 (fr) 2023-01-04
SG11202112374YA (en) 2021-12-30
US20230346002A1 (en) 2023-11-02
US11730187B2 (en) 2023-08-22
WO2020227512A1 (fr) 2020-11-12
US20200352215A1 (en) 2020-11-12
EP3955754A1 (fr) 2022-02-23
CN114340410A (zh) 2022-04-12
EP3955754C0 (fr) 2026-03-11
EP3955754B1 (fr) 2026-03-11
JP2022539648A (ja) 2022-09-13

Similar Documents

Publication Publication Date Title
Lange et al. Effects of smoking and changes in smoking habits on the decline of FEV1
Ginzkey et al. Analysis of nicotine-induced DNA damage in cells of the human respiratory tract
Kırkıl et al. Antioxidant effect of zinc picolinate in patients with chronic obstructive pulmonary disease
JP7579581B2 (ja) 無煙たばこ製品におけるイソチオシアネートの使用
El-Kenawy et al. Effects of Physalis peruviana L. on toxicity and lung cancer induction by nicotine derived nitrosamine ketone in rats
Li et al. Chemopreventive activity of selenocysteine prodrugs against tobacco‐derived nitrosamine (NNK) induced lung tumors in the A/J mouse
Trybek et al. The effect of n‪ icotine on oral health
Patil et al. Aqueous extract of tobacco induces mitochondrial potential dependent cell death and epithelial-mesenchymal transition in gingival epithelial cells
Hamner III et al. Altered staining reaction of connective tissues in 53 submucous fibrosis patients
CN103211298A (zh) 铁皮石斛多糖在制备减害香烟中的应用
OA20552A (en) Use of isothiocyanate in smokeless tobacco products.
CN107661481A (zh) 一种治疗耳鸣的药物及其制备方法和用途
Theophilus et al. Toxicological evaluation of expanded shredded tobacco stems
Arise et al. Taurine and vitamin E protect against pulmonary toxicity in rats exposed to cigarette smoke
Abro et al. Smoking and oral cancer
Gupta et al. Effect of cigarette smoke inhalation on benzo [a] pyrene-induced lung carcinogenesis in vitamin A deficiency in the rat
Theophilus et al. Toxicological evaluation of dry ice expanded tobacco
Ayuningtyas et al. The increase of dysplasia level in Wistar rats oropharyngeal mucosa exposed by sidestream cigarette smoke
Rayner et al. Cigarette smoke preparations, not electronic nicotine delivery systems (ENDS) preparations, induce features of lung disease in a 3D lung repeat-dose model
JONES et al. Oral Cancer and Associated
Boffano et al. Cigarettes Versus Electronic Cigarettes: The Effects on The Oral Cavity.
Lee et al. The risk of oropharyngeal cancer from E-cigarette use: an urgent public health concern
Zailani et al. The Usage of E-Cigarette in Curbing Tobacco Addiction: A Baseline Study
Devita Effect of smoking on follicle-stimulating hormone, luteinizing hormone and testosterone in men
Hawari Tobacco dependence; the whole story

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220901

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20220927

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220927

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230327

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230327

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240528

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240823

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240924

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241021

R150 Certificate of patent or registration of utility model

Ref document number: 7579581

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150